c-Jun antibody | knockout validation | Cell Signaling 9165

This is a knockout-validated antibody summary, based on the publications "Tead and AP1 Coordinate Transcription and Motility", as cited below [1], and "KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer" for western blot knockout validation (figure 4b) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

c-Jun antibody | knockout validation | Cell Signaling 9165 figure 1
Figure 1. Immunoblot analysis of c-Jun expression in HCT116 cells with and without expression of Cripsr knockout constructs against cJun. GAPDH was used as loading control. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: c-Jun

Catalog number: 9165

Summary: Rabbit monoclonal IgG against a GST-fusion protein corresponding to the amino-terminal sequence of human c-Jun. Reacts with human, mouse, rat, and monkey. Suitable for western blot, immunoprecipitation, immunohistochemistry (paraffin and frozen), immunofluorescence/immunocytochemistry) and ChIP.

Validation Method

Western blot

Sample

Control and c-Jun-KO HCT116 cells.

Secondary incubation

HRP conjugated secondary antibodies (Jackson Laboratories).

References
  1. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed publisher
  2. Kim K, Kabra A, Kim D, Xue Y, Huang Y, Hou P, et al. KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. Sci Adv. 2022;8:eabl4618 pubmed publisher